ECU offers innovative and practical courses across a variety of disciplines and we have a vibrant research culture. ECU is a leader in developing alternative entry pathways to higher education.
We have three campuses in Western Australia. Joondalup and Mount Lawley in the Perth metropolitan area and our South West campus in Bunbury, 200km south of the Perth CBD.
ECU provides a variety of services and facilities that go beyond the classroom, with opportunities for personal development and social interaction for students and staff.
We collaborate with all types of businesses, including new start-ups, small to medium enterprises, not-for-profits, community organisations, government and large corporates in the resources sector.
Children's University Edith Cowan aims to inspire students between seven and fourteen to develop confidence and a love of learning through validated activities beyond the school curriculum.
The Inspiring Minds scholarship program are equity scholarships that give students an opportunity to access an education that may otherwise be out of reach.
Marston, K., De Frutos-Lucas, J., Porter, T., Milicic, L., Vacher, M., Sewell, K., Peiffer, J., Laws, S., Brown, B. (2024). Exploration of Alzheimer's disease-related gene expression following high-intensity and moderate-intensity exercise interventions. Journal of Science and Medicine in Sport, 2024(Article in press), 6 pages. https://doi.org/10.1016/j.jsams.2024.07.017.
Schäfer Hackenhaar, F., Josefsson, M., Nordin Adolfsson, A., Landfors, M., Kauppi, K., Porter, T., Milicic, L., Laws, S., Hultdin, M., Adolfsson, R., Degerman, S., Pudas, S. (2023). Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer's Disease. Journal of Alzheimer's Disease, 94(4), 1443-1464. https://doi.org/10.3233/JAD-230039.
Milicic, L., Porter, T., Vacher, M., Laws, S. (2023). Utility of DNA Methylation as a Biomarker in Ageing and Alzheimer’s Disease. Journal of Alzheimer's Disease Reports, 7(1), 475-503. https://doi.org/10.3233/ADR-220109.
Vacher, M., Dore, V., Porter, T., Milicic, L., Villemagne, V., Bourgeat, P., Burnham, S., Cox, T., Masters, C., Rowe, C., Fripp, J., Doecke, J., Laws, S. (2022). Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer’s disease. BMC Genomics, 23(1), Article 401. https://doi.org/10.1186/s12864-022-08617-2.
Vacher, M., Porter, T., Milicic, L., Bourgeat, P., Dore, V., Villemagne, V., Laws, S., Doecke, J. (2022). A Targeted Association Study of Blood-Brain Barrier Gene SNPs and Brain Atrophy. Journal of Alzheimer's Disease, 86(4), 1817-1829. https://doi.org/10.3233/JAD-210644.
Roe, J., Vidal-Piñeiro, D., Sørensen, ., Brandmaier, A., Düzel, S., Gonzalez, H., Kievit, R., Knights, E., Kühn, S., Lindenberger, U., Mowinckel, A., Nyberg, L., Park, D., Pudas, S., Rundle, M., Walhovd, K., Fjell, A., Westerhausen, R., Masters, C., Bush, A., Fowler, C., Darby, D., Pertile, K., Restrepo, C., Roberts, B., Robertson, J., Rumble, R., Ryan, T., Collins, S., Thai, C., Trounson, B., Lennon, K., Li, Q., Ugarte, F., Volitakis, I., Vovos, M., Williams, R., Baker, J., Russell, A., Peretti, M., Milicic, L., Lim, L., Rodrigues, M., Taddei, K., Taddei, T., Hone, E., Lim, F., Fernandez, S., Rainey-Smith, S., Pedrini, S., Martins, R., Doecke, J., Bourgeat, P., Fripp, J., Gibson, S., Leroux, H., Hanson, D., Dore, V., Zhang, P., Burnham, S., Rowe, C., Villemagne, V., Yates, P., Pejoska, S., Jones, G., Ames, D., Cyarto, E., Lautenschlager, N., Barnham, K., Cheng, L., Hill, A., Killeen, N., Maruff, P., Silbert, B., Brown, B., Sohrabi, H., Savage, G., Vacher, M. (2021). Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer’s disease. Nature Communications, 12(1), Article number 721. https://doi.org/10.1038/s41467-021-21057-y.
Tan, S., Porter, T., Bucks, R., Weinborn, M., Milicic, L., Brown, A., Rainey-Smith, S., Taddei, K., Ames, D., Masters, C., Maruff, P., Savage, G., Rowe, C., Villemagne, V., Brown, B., Sohrabi, H., Laws, S., Martins, R. (2021). Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognition. Hormones and Behaviour, 131(May 2021), Article number 104966. https://doi.org/10.1016/j.yhbeh.2021.104966.
Fowler, C., Rainey-Smith, S., Bird, S., Bomke, J., Bourgeat, P., Brown, B., Burnham, S., Bush, A., Chadunow, C., Collins, S., Doecke, J., Dore, V., Ellis, K., Evered, L., Fazlollahi, A., Fripp, J., Kirby, S., Gibson, S., Grenfell, R., Harrison, E., Head, R., Jin, L., Kamer, A., Lamb, F., Lautenschlager, N., Laws, S., Li, Q., Lim, L., Lim, Yy., Louey, A., Macaulay, L., Mackintosh, L., Martins, R., Maruff, P., Masters, C., McBride, S., Milicic, L., Peretti, M., Pertile, K., Porter, T., Radler, M., Rembach, A., Robertson, J., Rodriguez, M., Rowe, C., Rumble, R., Salvado, O., Savage, G., Silbert, B., Soh, M., Sohrabi, H., Taddei, K., Taddei, T., Thai, C., Trounson, B., Tyrell, R., Vacher, M., Varghese, S., Villemagne, V., Weinborn, M., Woodward, M., Xia, Y., Ames, D. (2021). Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and observations from 2,359 older adults spanning the spectrum from cognitive normality to Alzheimer's disease. Journal of Alzheimer's Disease Reports, 5(1), 443-468. https://doi.org/10.3233/ADR-210005.
Fernandez, S., Burnham, S., Milicic, L., Savage, G., Maruff, P., Peretti, M., Sohrabi, H., Lam, YY., Weinborn, M., Ames, D., Masters, C., Martins, R., Rainey-Smith, S., Rowe, C., Salvado, O., Groth, D., Verdile, G., Villemagne, V., Porter, T., Laws, S. (2021). SPON1 Is Associated with Amyloid-β and APOE ε4-Related Cognitive Decline in Cognitively Normal Adults. Journal of Alzheimer's Disease Reports, 5(1), 111-120. https://doi.org/10.3233/ADR-200246.
Porter, T., Burnham, S., Milicic, L., Savage, G., Maruff, P., Sohrabi, H., Peretti, M., Lim, YY., Weinborn, M., Ames, D., Masters, C., Martins, R., Rainey-Smith, S., Rowe, C., Salvado, O., Groth, D., Verdile, G., Villemagne, V., Laws, S. (2019). COMT val158met is not associated with Aβ-amyloid and APOE ε4 related cognitive decline in cognitively normal older adults. IBRO Reports, 6(June 2019), 147-152. https://doi.org/10.1016/j.ibror.2019.05.001.
Porter, T., Burnham, S., Milicic, L., Savage, G., Maruff, P., Lim, YY., Ames, D., Masters, C., Martins, R., Rainey-Smith, S., Rowe, C., Salvado, O., Groth, D., Verdile, G., Villemagne, V., Laws, S. (2019). Klotho allele status is not associated with Ab and APOE ε4erelated cognitive decline in preclinical Alzheimer’s disease. Neurobiology of Aging, 76(April 2019), 162-165. https://doi.org/10.1016/j.neurobiolaging.2018.12.014.
Vacher, M., Porter, T., Villemagne, V., Milicic, L., Peretti, M., Fowler, C., Martins, R., Rainey-Smith, S., Ames, D., Masters, C., Rowe, C., Doecke, J., Laws, S. (2019). Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition. Scientific Reports, 9(2019), Article number 17069. https://doi.org/10.1038/s41598-019-53604-5.
Porter, T., Burnham, S., Savage, G., Lim, YY., Maruff, P., Milicic, L., Peretti, M., Ames, D., Masters, C., Martins, R., Rainey-Smith, S., Rowe, C., Salvado, O., Taddei, K., Groth, D., Verdile, G., Villemagne, V., Laws, S. (2018). A polygenic risk score derived from episodic memory weighted genetic variants is associated with cognitive decline in preclinical Alzheimer's disease. Frontiers in Aging Neuroscience, 10(Dec 2018), Article number 423. https://doi.org/10.3389/fnagi.2018.00423.
Porter, T., Burnham, S., Dore, V., Savage, G., Bourgeat, P., Begemann, K., Milicic, L., Ames, D., Bush, A., Maruff, P., Masters, C., Rowe, C., Rainey-Smith, S., Martins, R., Groth, D., Verdile, G., Villemagne, V., Laws, S. (2018). KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4- positive cognitively normal adults with high Aβ-amyloid burden. Scientific Reports, 8(1), Article no.2034. https://doi.org/10.1038/s41598-018-20513-y.
Porter, T., Burnham, S., Milicic, L., Savage, G., Maruff, P., Lim, YY., Li, Q., Ames, D., Masters, C., Rainey-Smith, S., Rowe, C., Salvado, O., Groth, D., Verdile, G., Villemagne, V., Laws, S. (2018). Utility of an Alzheimer’s Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer’s Disease: A Prospective Longitudinal Study. Journal of Alzheimer's Disease, 66(3), 1193-1211. https://doi.org/10.3233/JAD-180713.
Porter, T., Villemagne, V., Savage, G., Milicic, L., Lim, YY., Maruff, P., Masters, C., Ames, D., Bush, A., Martins, R., Rainey-Smith, S., Rowe, C., Taddei, K., Groth, D., Verdile, G., Burnham, S., Laws, S. (2018). Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer’s disease. Personalized Medicine in Psychiatry, 7-8(2018), 14-20. https://doi.org/10.1016/j.pmip.2018.03.001.
Pietrzak, RH., Laws, S., Lim, YY., Bender, SJ., Porter, T., Doecke, J., Ames, DJ., Fowler, CJ., Masters, CL., Milicic, L., Rainey-Smith, S., Villemagne, VL., Rowe, CC., Martins, R., Maruff, P. (2017). Plasma Cortisol,Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer’s Disease: A 6-Year Prospective Cohort Study. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2(1), 45-52. https://doi.org/10.1016/j.bpsc.2016.08.006.
Research Projects
Investigating changes in DNA Methylation age in Alzheimer’s disease , Australian Alzheimer's Research Foundation, Scholarships to support Industry Engagement PhD Projects, 2019 ‑ 2022, $17,500.
Help us improve our content
Please leave a comment about your rating so we can better understand how we might improve the page.